Nanoform’s positive commercial momentum continues
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has continued to see positive commercial momentum since its June 4[th], 2020 initial public offering. Despite the ongoing COVID-19 pandemic the company has been able to show progress by signing two experienced commercialization experts in the U.